CROMBEZ ERIC (EVP and Chief Medical Officer) sold 8.4% of their position (7.03K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $160.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001193125-26-089104
Officer· EVP and Chief Medical Officer
Since Mar 2026
+4.61K
Net shares
Net buyer
$160.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
11.64K acquired · 7.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.64K
Price / share
—
Trade value
—
% of position
16.3%
3/1/2026
71.53K→83.17K
Common Stock
Direct
Shares
−7.03K
Price / share
$22.80
Trade value
$160.26K
% of position
8.4%
3/2/2026
83.33K→76.30K
Total
Net shares
+4.61K
Net value
-$160.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +11.64K | — | — | 16.3% | 71.53K | 83.17K |
| Common Stock Direct | 3/2/2026 | S · Sale | −7.03K | $22.80 | $160.26K | 8.4% | 83.33K | 76.30K |
| Total | +4.61K | -$160.26K | ||||||
Derivative Transactions0
No derivative transactions reported